TY - JOUR
T1 - Hospitalization rates and clinical performance measures in U.S. adolescent hemodialysis patients
AU - Gorman, Gregory
AU - Neu, Alicia
AU - Fivush, Barbara
AU - Frankenfield, Diane
AU - Furth, Susan
N1 - Funding Information:
This study was supported by grant R21 DK64313 from the National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland. This study was presented at the American Society of Nephrology in Philadelphia, PA in October 2005 and at the American Society of Pediatric Nephrology meeting in San Francisco on April 30, 2006.
PY - 2010/11
Y1 - 2010/11
N2 - The Centers for Medicare and Medicaid Services' End Stage Renal Disease (ESRD) Clinical Performance Measures (CPM) Project monitors clinical measure attainment in pediatric hemodialysis (HD) patients. Targets include hemoglobin ≥11 g/dL, albumin ≥3.5/3.2 g/dL (bromcresol green/purple), single-pooled Kt/V ≥1.2, and the use of subcutaneous access. We hypothesized that the achievement of multiple targets by adolescent HD patients is associated with decreased morbidity. Data on patients aged 12-18 years included in the ESRD CPM Project from 2000 to 2004 with Medicare as primary payer were linked to the U.S. Renal Data System data from October 1, 1999 to December 31, 2004. Hospitalization rates by number of targets achieved were determined with Poisson regression analysis adjusted for dialysis vintage, short stature, and race. A total of 1534 patients with 1774 patient-years of follow-up, with 580 hospitalizations, were included in the analysis. In their first year in the ESRD CPM Project, 22% of the patients achieved four targets, with 34 and 28% achieving three and two targets, respectively. Subcutaneous access was least frequently attained target; spKt/V ≥ 1.2 was the most frequently attained target. After adjustment, there was decreased hospitalization risk with increasing target attainment (incidence rate ratio 0.74, 95% confidence interval 0.67-0.80, p < 0.001). Based on this analysis, meeting adult-defined targets is associated with decreases in the hospitalization rate of adolescent HD patients. Tracking adult-defined HD measures is appropriate for assessing hospitalization risk in adolescent patients, although no evidence for a cause-and-effect relationship exists.
AB - The Centers for Medicare and Medicaid Services' End Stage Renal Disease (ESRD) Clinical Performance Measures (CPM) Project monitors clinical measure attainment in pediatric hemodialysis (HD) patients. Targets include hemoglobin ≥11 g/dL, albumin ≥3.5/3.2 g/dL (bromcresol green/purple), single-pooled Kt/V ≥1.2, and the use of subcutaneous access. We hypothesized that the achievement of multiple targets by adolescent HD patients is associated with decreased morbidity. Data on patients aged 12-18 years included in the ESRD CPM Project from 2000 to 2004 with Medicare as primary payer were linked to the U.S. Renal Data System data from October 1, 1999 to December 31, 2004. Hospitalization rates by number of targets achieved were determined with Poisson regression analysis adjusted for dialysis vintage, short stature, and race. A total of 1534 patients with 1774 patient-years of follow-up, with 580 hospitalizations, were included in the analysis. In their first year in the ESRD CPM Project, 22% of the patients achieved four targets, with 34 and 28% achieving three and two targets, respectively. Subcutaneous access was least frequently attained target; spKt/V ≥ 1.2 was the most frequently attained target. After adjustment, there was decreased hospitalization risk with increasing target attainment (incidence rate ratio 0.74, 95% confidence interval 0.67-0.80, p < 0.001). Based on this analysis, meeting adult-defined targets is associated with decreases in the hospitalization rate of adolescent HD patients. Tracking adult-defined HD measures is appropriate for assessing hospitalization risk in adolescent patients, although no evidence for a cause-and-effect relationship exists.
KW - Guidelines
KW - Hemodialysis
KW - Outcomes
KW - Pediatrics
UR - http://www.scopus.com/inward/record.url?scp=77957274196&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77957274196&partnerID=8YFLogxK
U2 - 10.1007/s00467-010-1597-8
DO - 10.1007/s00467-010-1597-8
M3 - Article
C2 - 20668886
AN - SCOPUS:77957274196
SN - 0931-041X
VL - 25
SP - 2335
EP - 2341
JO - Pediatric Nephrology
JF - Pediatric Nephrology
IS - 11
ER -